Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02442401

Enrollment

Registered

2015-05-13

Start date

2009-01-31

Completion date

2012-12-31

Last updated

2015-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction, Latissimus Dorsi Flap, NPWT

Brief summary

The use of NPWT as a post-operative dressing significantly reduces the incidence of seroma formation after harvesting LD flap.

Detailed description

NPWT was left in place on donor site with constant pressure between -125 and -80 mmHg to reduce seroma formation

Interventions

DEVICEThe negative pressure wound therapy

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Age between 20-60 years Underwent breast reconstruction with LD Flap

Exclusion criteria

* Locally advanced cancer

Design outcomes

Primary

Measure	Time frame
Incidence of seroma	3 months

Secondary

Measure	Time frame
Aspirated Volume	3 months
Frequency of Aspiration	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026